Gastroenterology/IBD
| 09.45-10.00 |
Begrüssung / Introduction
Stephan Brand, St.Gallen, Switzerland |
| 10.00-10.30 |
Getting personal: A very personal view on personalized medicine in IBD in 2024 Personalisierte
Stephan Brand, St.Gallen, Switzerland |
| 10.30-11.00 |
The role of anti-IL-23 antibodies in the IBD therapy: For whom and when?*
Marc Ferrante, Leuven, Belgium |
| 11.00-11.30 |
Current and future treatment algorithms in IBD: Will disease clearance and molecular healing become possible?*
Laurent Peyrin-Biroulet, Nancy, France |
| 11.30-12.00 |
Updated ECCO Guidelines on therapeutics in Crohn's disease: How to treat Crohn’s disease in 2024?*
Tim Raine, Cambridge, United Kingdom |
| 12.00-13.00 | Mittagspause und Besuch der Industrieausstellung |
Endoscopy
| 13.00-13.30 |
The earlier the better: Role of endoscopy in the diagnosis of early gastrointestinal cancers and dysplasia
Jan Borovicka, St. Gallen, Switzerland |
| 13.30-14.00 |
Artificial intelligence for colorectal adenoma detection*
Raf Bisschops, Leuven, Belgium |
| 14.00-14.30 |
Cutting edge: Endoscopic therapy of early gastrointestinal cancers and dysplasia
Remus Frei, St. Gallen, Switzerland |
| 14.30-15.00 |
New Guidelines for eosinophilic esophagitis, reflux disease, and Barrett’s esophagus: What should I know?
Oliver Pech, Regensburg, Germany |
| 15.00-15.30 | Kaffeepause und Besuch der Industrieausstellung |
Hepatology
| 15.30-16.00 |
Hepatocellular carcinoma: Diagnostics and treatment update 2024
David Semela, St. Gallen, Switzerland |
| 16.00-16.30 |
Hemochromatosis and metabolic hyperferritinaemia
Markus Heim, Basel, Switzerland |
| 16.30-17.00 |
Management of portal vein thrombosis
Andrea de Gottardi, Luzern, Switzerland |
| 17.00-17.30 |
Primary biliary cholangitis and primary sclerosing cholangitis: Update 2024*
Gideon Hirschfield, Toronto, Canada |
| 17.30-17.35 |
Schlusswort / Closing remarks
Stephan Brand, St.Gallen, Switzerland |
*Vorträge, die mit einem Stern gekennzeichnet sind, werden in Englisch gehalten